Patient characteristics | |
Sex (male/female) | 56/44 |
Age (years)a | 12.5 ± 6.3; 1–33 |
Age at symptom-onset (years)a | 3.3 ± 4.6; 0–18 |
Duration of symptoms (years)a | 9.2 ± 6.3; 1–32 |
Referral questions | |
Movement disorder classification | 50 |
Etiology | 38 |
Treatment | 42 |
MD classification | |
Ataxia | 9 |
Dystonia | 32 |
Myoclonus | 11 |
Otherb | 12 |
Unclassified | 36 |
Etiological diagnosis | |
Inherited etiologies | 17 |
Monogenic | |
ARX mutation | 1 |
Ataxia telangiectasia | 1 |
Coffin Lowry syndrome | 1 |
Glutaric aciduria type 1 | 2 |
GLI2 mutation | 1 |
GOSR2 mutation | 1 |
GTPCH deficiency (DYT5) | 1 |
Proprionacidemia | 1 |
SCN1A mutation | 2 |
THAP1 mutation (DYT6) | 2 |
TITF1 mutation | 1 |
Structural chromosomal abnormality | |
Microdeletion 19p13.2p13.13 (NFIX and CACNA1A gene) | 1 |
Partial deletion chromosome 7q (SCGE gene) | 1 |
Uniparental disomia chromosome 7 (SCGE gene) | 1 |
Acquired etiologies | 12 |
Infectious | 2 |
Perinatal asphyxia | 9 |
Functional | 2 |